Pharmacotherapy for smoking cessation during pregnancy and the inter-pregnancy period: a population-based cohort study

怀孕期间和怀孕期间戒烟的药物治疗：一项基于人群的队列研究

• 批准号: nhmrc : 1028543
• 负责人: A/Pr Kristjana Einarsdottir
• 金额: $ 43.6万
• 依托单位: The University of New South Wales
• 依托单位国家: 澳大利亚
• 项目类别: Project Grants
• 财政年份: 2012
• 资助国家: 澳大利亚
• 起止时间: 2012-01-01 至 2017-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/pharmacotherapy-smoking-cessation-cohort-study/110643
• 关键词: Pharmacotherapy; smoking; cessation; during; pregnancy

This study will examine the effectiveness and safety of medications for smoking cessation prior to and during pregnancy. It will achieve this by linking routinely collected midwives data from NSW and WA to prescriptions records and other health service use. It will explore potential inequalities in the use and effectiveness of these medications in disadvantaged populations, including Aboriginal women, and it will investigate whether their use has changed in response to policy changes.

这项研究将检查怀孕前和怀孕期间戒烟药物的有效性和安全性。它将通过将新南威尔士州和西澳定期收集的助产士数据与处方记录和其他卫生服务使用联系起来来实现这一目标。它将探讨这些药物在包括土著妇女在内的弱势群体中使用和有效性方面的潜在不平等，并将调查这些药物的使用是否因政策变化而改变。